CDEK
← All drugs Report issue

gingko biloba

Botanicalexperimental

Ginkgo biloba, commonly known as ginkgo, also known as the maidenhair tree, and often misspelled "gingko" is a species of gymnosperm tree native to East Asia. It is the last living species in the order Ginkgoales, which first appeared over 290 million years ago. Fossils similar to the living species, belonging to the genus Ginkgo, extend back to the Middle Jurassic epoch approximately 170 million years ago. The tree was cultivated early in human history, remains commonly planted, and is widely regarded as a living fossil. — Wikipedia

Clinical trial activity

20 trials · 30 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
13
Phase 3
6
Phase 4
2

Earliest trial started Jul 1, 2001 (NCT00070161)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • egb761
  • egb761
  • egb761
  • egb 761
  • egb-761
  • gbe 761
  • gbe-761
  • gbe 761 onc
  • gingko biloba extract
  • ginkgo biloba extract
  • ginkgo biloba extract
  • ginkgo biloba extract 761
  • ginkgo leaf extract
  • rokan
  • tanakan
  • tebofortran
  • tebokan
  • tebonin
  • yy-162

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06989697Phase 3Jan 1, 2025Seoul National University, SK Chemicals
NCT06583941N/ASep 30, 2024Lonza
NCT05594355Phase 4Apr 16, 2021Fundació ACE
NCT04525144Phase 2Sep 30, 2020National Neuroscience Institute, Schwabe
NCT04499157N/AAug 31, 2020University of Picardie Jules Verne
NCT04492241N/AAug 1, 2020Beijing Stroke Association, Capital Medical University
NCT04448535N/AJul 31, 2020State University of New York
NCT03761992N/ANov 19, 2018Icahn School of Medicine at Mount Sinai
NCT03647384Phase 2Aug 22, 2018Beijing Xuanwu Traditional Chinese Medicine Hospital, Capital Medical University, China Academy of Chinese Medical Sciences, Chinese Academy of Medical Sciences, Fudan University, Henan Medical University, Peking University, Shaanxi University of Chinese Medicine, Shandong University, Shanghai University, Shanxi Medical University
NCT03228550Phase 2Feb 26, 2017Bournemouth University, Efamol Ltd, Sylvia Waddilove Foundation
NCT01536210Phase 3Dec 1, 2011Hallym University, Inje University, Seoul National University, Yuyu Pharma, Inc.
NCT01201187Phase 3Mar 1, 2010Hallym University, Inje University, Seoul National University, Yuyu Pharma, Inc.
NCT00814346Phase 2Oct 1, 2008Ipsen
NCT00824512Phase 2Jun 1, 2008Ipsen
NCT00672373Phase 3Dec 1, 2006Peking University
NCT00500500Phase 2Jul 1, 2005Ipsen
NCT00276341Phase 3Aug 1, 2003Ipsen
NCT00276380Phase 3Feb 1, 2003Ipsen
NCT00276510Phase 4Feb 1, 2002Ipsen
NCT00070161Phase 2Jul 1, 2001National Cancer Institute (NCI), Wake Forest University
Showing 20 of 20 trials
Page 1 / 1

Organizations

Research & Development (30)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
IpsenFor profit6632002
Seoul National UniversityAcademic/Hospital3112010
Capital Medical UniversityAcademic/Hospital2122018
Hallym UniversityAcademic/Hospital2012010
Inje UniversityAcademic/Hospital2012010
Peking UniversityAcademic/Hospital2122006
Yuyu Pharma, Inc.For profit2212010
Beijing Stroke AssociationAcademic/Hospital1012020
Beijing Xuanwu Traditional Chinese Medicine HospitalAcademic/Hospital1012018
Bournemouth UniversityAcademic/Hospital1112017
China Academy of Chinese Medical SciencesAcademic/Hospital1112018
Chinese Academy of Medical SciencesAcademic/Hospital1012018
Efamol LtdFor profit1012017
Fudan UniversityAcademic/Hospital1012018
Fundació ACEAcademic/Hospital1112021
Henan Medical UniversityAcademic/Hospital1012018
Icahn School of Medicine at Mount SinaiAcademic/Hospital1112018
LonzaFor profit1112024
National Cancer Institute (NCI)Government1012001
National Neuroscience InstituteGovernment1112020
30 organizations
Page 1 / 2